Memantine to prevent paclitaxel nerve damage in breast cancer
Part of Brain & nervous system, Cancer clinical trials.
This trial tests whether the drug memantine can help prevent or reduce nerve pain and other side effects caused by the chemotherapy drug paclitaxel in breast cancer patients. If you are about to start weekly paclitaxel, this study may offer extra protection to your nerves.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have breast cancer that has not spread to other parts of the body.
- You are scheduled to receive weekly paclitaxel (Taxol) as part of your treatment.
- You are able to perform daily activities (ECOG score 0-2).
- You do not have diabetes, nerve damage, or a history of seizures.
- You are not taking certain medications that affect nerves or interact with the study drug.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether two common medications, memantine and rosuvastatin, can protect nerves during colorectal cancer treatment. If you are about to start chemotherapy with FOLFOX or XELOX, this study may help reduce nerve damage.
This Phase 2 study tests whether a daily tablet (Onlife) can help prevent nerve side effects (“neurotoxicity”) caused by weekly paclitaxel given for breast cancer. You’d be randomly assigned to the tablet or a placebo, and you would be closely followed with questionnaires and clinic visits.
This trial tests whether a gel called TAR-0520 can prevent nerve damage (peripheral neuropathy) caused by common breast cancer drugs like paclitaxel or docetaxel. You'll apply the gel to your skin, and the study will see if it helps reduce numbness, tingling, or pain in your hands and feet.
This trial tests whether taking two natural plant compounds (hesperidin and diosmin) can help prevent the nerve damage (numbness, tingling, or pain in hands and feet) that often comes with the chemotherapy drug paclitaxel. It is for women with breast cancer who are about to start paclitaxel treatment.
This trial tests whether a drug called GM1 can prevent nerve damage (numbness, tingling, or pain in hands/feet) caused by a common chemotherapy drug used for breast cancer. If you are starting chemotherapy with nab-paclitaxel, this study may help protect your nerves.
This study looks at whether certain markers in your blood can predict nerve damage from paclitaxel chemotherapy. If you join, researchers will monitor your nerve health during treatment to better understand and possibly prevent side effects.
Hear when a new Breast Cancer Early Stage Breast Cancer (Stage 1-3) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.